Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies

Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies

Abstract Over the last decade, the emergence of several novel therapeutic approaches has changed the therapeutic perspective of human malignancies. Adoptive immunotherapy through chimeric antigen receptor T cell (CAR‐T), which includes the engineering of T cells to recognize tumor‐specific membrane...

Full description

Bibliographic Details
Main Authors: Samane Abbasi, Milad Asghari Totmaj, Masoumeh Abbasi, Saba Hajazimian, Pouya Goleij, Javad Behroozi, Behrouz Shademan, Alireza Isazadeh, Behzad Baradaran
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
chimeric antigen receptor T cells
hematological malignancies
immune therapy
T‐cell therapy
tumor immunology
Online Access:https://doi.org/10.1002/cam4.5551

Internet

https://doi.org/10.1002/cam4.5551

Similar Items